Synonym
Product Category
Product Code
CAS Number
MDL Number
Pubchem CID
Reaxys RN
ACT-064992
API & Intermediates
KAPI0F19
441798-33-0
MFCD17167076
16004692

Macitentan (also known as ACT-064992) is an orally active endothelin receptor antagonist for the treatment of pulmonary arterial hypertension (PAH).
Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist. [1]
Macitentan: entry-into-humans study with a new endothelin receptor antagonist. [2]
Macitentan for the treatment of pulmonary arterial hypertension. [3]
Complement-binding anti-HLA antibodies and kidney transplantation. [4]
References:
[1] M.Iglarz, et al, J. Pharmacol. Exp. Ther., 2008, 327(3), pp 736-745.
[2] P.N.Sidharta. et al, Eur. J. Clin. Pharmacol., 2011, 67(10), pp 977-984.
[3] I.S. Hong, et al, Ann. Pharmacother., 2014, 48(4), pp 538-547.
[4] C.Lawrence, et al, N. Engl. J. Med., 2014, 370(1), pp 84-85.
Signal Word
Hazard Statements
Precautionary Statements
HS Code
RIDADR
Legal Information
Not classified as a dangerous goods
NONH for all modes of transport
Sales restrictions may apply.
1. Product Specification
2. Safety Data Sheet
Available on request.
Please inquire for pricing and availability of this product by writing email to sales@kumidas.com.